Middle East and Africa Knee Reconstruction Devices Market Research Report – Segmented By Product Type and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Size, Share, Trends and Growth Forecast (2024 to 2029)

Updated On: January, 2024
ID: 7517
Pages: 145

MEA Knee Reconstruction Devices Market Size (2024 to 2029)

The size of the Knee Reconstruction Devices Market in the Middle East and Africa was worth USD 30.77 billion in 2024 and estimated to be growing at a CAGR of 4.1%, to reach USD 37.62 billion by 2029.

The MEA knee reconstruction devices market is driven by factors such as the growth of an aging population and the increasing prevalence of arthritis, technological development, and suitable healthcare policies in most countries. Additionally, many countries in the continent have become healthcare tourism points for knee reconstruction surgeries, as they provide quality treatment at affordable prices. Using artificial knee implants, total joint replacement of a dysfunctional knee has been a reliable and efficient treatment method. It provides a significant improvement in patients' performance and quality of life across the Middle East and Africa. Knee pain, caused by musculoskeletal diseases like osteoarthritis (OA), is a quickly growing disease estimated to increase the substantial demand for knee reconstruction surgeries in the future years.

The growing aging population suffering from knee-relevant disorders such as arthritis and osteoarthritis is market growth.

The market players focus strongly on inventing or implementing new devices to reconstruct the knee, growing obesity. Obese people gain more weight making them unable to walk as the whole-body weight pressurizes the knee. The deep-rooted healthcare structure and high occurrence of arthritis in aged people boosted the market growth during the assessment period. The growing number of hospitals with expert professionals, the rising patient count, the number of product approvals, and the introduction of new devices into the markets.

The surging number of knee-implants, growing vast number of bone-relevant illnesses, and frequent prevalence of accidents push the market forward. In October 2014, Zimmer Holdings, Inc. obtained ETEX Holdings, which has advanced, produced, and commodified biomaterials for developed orthopedic clinical results. Nearly 67 million people are to be affected by arthritis by 2030, according to the Arthritis Foundation. 

The prising pressure of the knee reconstruction devices is one of the significant factors limiting the market growth. In addition, a product recall is another significant challenging factor in the knee reconstruction devices market in the MEA region.

This research report on the Middle East and Africa knee reconstruction devices market has been segmented and sub-segmented into the following categories.

By Product Type

  • Primary Cemented

  • Primary Cementless
  • Partial
  • Revision Implants

By Country

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Physical inactivity due to sedentary lifestyle fuelling obesity and lifestyle disorder prevalence are key drivers for the market. According to the NCBI, as of October 2018, in Saudi Arabia, obesity was 24.1% in women and 33.5% in men. It also stated that no low-level physical activity was observed in 46% of men and 75.1% of women. Excess weight stresses the weight-bearing joints, like the hips and knees, which leads to pain in these joints and other ailments. In addition, people who are obese are more likely to develop osteoarthritis than those who are not.

The market participants are also affected by COVID-19. For instance, Medtronic reported a 44.0% drop in its quarterly income compared to the previous year. The primary reason behind this was the postponement of many surgical procedures. However, with easing lockdown restrictions, vaccination, and resumption of elective surgeries, the market is expected to pick up the pace in the next two years.

The market is highly competitive, and a limited number of players have a high level of dominance over the overall revenue share. The most notable market participants are DJO, LLC, Smith + Nephew, Zimmer Biomet, B.Braun Melsungen AG, Conmed Corporation, DePuy Synthes, Meril Life Sciences Pvt. Ltd., and Arthrex, Inc. They account for a considerable share owing to their product offerings to the market. In addition, market leaders are involved in the establishment of extensive distribution systems as well as increasingly involved in mergers and acquisitions to capture a larger share of the market. For instance, in January 2022, DJO, LLC, a part of Colfax, acquired Trilliant Surgical. This furthered the company’s expansion into the growing foot and ankle surgery market. Therefore, steady growth is predicted from the MEA knee reconstruction devices market during the forecast period.

In the MEA region, the Middle East is dominating the market. In Israel, the market is anticipated to register a CAGR of 5.3% in the coming years. Technological advancements and increasing awareness about health are primarily driving the market in the country.

After the Middle East, Africa has the largest share in the MEA knee reconstruction devices market. In South Africa, the prevalence of osteoarthritis accounts for between 29.5% and 82.7% in adults over 65 years of age in rural settings and 55.1% in urban environments. The prevalence of osteoarthritis is high in the country, which is likely to contribute to market growth over the forecast period significantly.


Companies playing a pivotal role in the MEA knee reconstruction devices market analyzed in this report are Zimmer, Inc., Stryker, DePuy Synthes, Smith & Nephew plc, Arthrex, Inc., Exactech, Inc., Corin, DJO North America, Japan Medical Dynamic Marketing, Inc.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample